Related Experiment Video
Updated: Jun 6, 2025
Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
How to Estimate the Minimal Clinically Important Difference: An Overview
Hernan Roca1, Gretchen Maughan, Brian Karamian
1Department of Orthopaedics, University of Utah, Salt Lake City, UT.
Abstract:
The minimal clinically important difference (MCID) is a threshold above which a score change would represent a change in symptoms that is noticeable by patients, and it has become a standard approach in the interpretation of clinical relevance of changes in PROMs at a population level. Given the lack of a methodological gold standard, high variability is the main limitation of MCID. Reporting both anchor and distribution-based MCID estimates is a strategy that guarantees both patient-perceived clinical relevance and statistical significance.
Insights
The minimal clinically important difference (MCID) helps interpret patient-reported outcome measure (PROM) changes. Reporting both anchor and distribution-based MCID estimates ensures patient-perceived relevance and statistical significance.
Area of Science:
- Health outcomes research
- Clinical trial methodology
Background:
- The minimal clinically important difference (MCID) is crucial for interpreting changes in patient-reported outcome measures (PROMs).
- It represents a threshold for patient-perceived symptom changes, vital for population-level analysis.
- High variability in MCID estimates is a significant limitation due to the absence of a gold standard methodology.
Purpose of the Study:
- To address the variability in MCID estimation.
- To propose a strategy for robust MCID determination.
- To ensure both patient-relevance and statistical validity in PROM interpretation.
Main Methods:
- Review of existing MCID methodologies.
- Comparison of anchor-based and distribution-based approaches.
- Synthesis of strategies for improved MCID estimation.
Main Results:
- MCID estimation is characterized by high variability.
- Anchor-based methods capture patient-perceived relevance.
- Distribution-based methods provide statistical significance.
Conclusions:
- Reporting both anchor-based and distribution-based MCID estimates is recommended.
- This dual approach enhances the clinical relevance and statistical validity of PROM changes.
- This strategy improves the interpretation of PROMs at a population level.
Related Concept Videos
01:05Difference from Background: Limit of Detection
The LOD indicates the presence or absence...
01:13Multiple Comparison Tests
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:19Testing a Claim about Standard Deviation
The hypothesis testing for the claim of population standard deviation (or variance) requires the data and samples to be random and unbiased. The population distribution also must be normal. There is no specific requirement on the sample size as the estimation is based on the chi-square distribution.
As a first step, the hypothesis (null and alternative) concerning the claim about...